Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

CG Goetz, BC Tilley, SR Shaftman… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

…, M Kaste, JR Marler, SA Hamilton, BC Tilley… - The Lancet, 2010 - thelancet.com
Background Early administration of intravenous recombinant tissue plasminogen activator (rt-PA)
after ischaemic stroke improves outcome. Previous analysis of combined data from …

Transfusion of plasma, platelets, and red blood cells in a 1: 1: 1 vs a 1: 1: 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial

JB Holcomb, BC Tilley, S Baraniuk, EE Fox, CE Wade… - Jama, 2015 - jamanetwork.com
Importance Severely injured patients experiencing hemorrhagic shock often require massive
transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red …

[HTML][HTML] Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of …

…, RI Lindley, G Murray, JM Olivot, M Parsons, B Tilley… - The Lancet, 2014 - thelancet.com
Background Alteplase is effective for treatment of acute ischaemic stroke but debate continues
about its use after longer times since stroke onset, in older patients, and among patients …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan

…, GT Stebbins, MB Stern, BC Tilley… - Movement …, 2007 - Wiley Online Library
This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council …

…, J Grotta, C Kase, D Krieger, M Mayberg, B Tilley… - Stroke, 1999 - Am Heart Assoc
Intracerebral hemorrhage (ICH) is more than twice as common as subarachnoid hemorrhage
(SAH) and is much more likely to result in death or major disability than cerebral infarction …

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison …

…, DJ Burn, J Jankovic, TK Khoo, BC Tilley - Movement …, 2013 - Wiley Online Library
Background Formulas were developed to define tremor dominant (TD) and postural
instability/gait difficulty (PIGD) phenotypes of Parkinson's Disease (PD) using the Movement …

[HTML][HTML] Effects of tissue plasminogen activator for acute ischemic stroke at one year

…, RB Libman, M Frankel, BC Tilley… - … England Journal of …, 1999 - Mass Medical Soc
Background In 1995, the two-part National Institute of Neurological Disorders and Stroke (NINDS)
Recombinant Tissue Plasminogen Activator Stroke Study found that patients who …

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial

…, JM Yamal, S Gopinath, JC Goodman, BC Tilley… - Jama, 2014 - jamanetwork.com
Importance There is limited information about the effect of erythropoietin or a high hemoglobin
transfusion threshold after a traumatic brain injury. Objective To compare the effects of …

Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial

BC Tilley, GS Alarcon, SP Heyse… - Annals of internal …, 1995 - acpjournals.org
Objective: To assess the safety and efficacy of minocycline in the treatment of rheumatoid
arthritis. Design: A double-blind, randomized, multicenter, 48-week trial of oral minocycline (…